Physician profile
Ami Abraham
NPI 1790947232
$2,407.14
in general payments reported to CMS, 2019-2025
18 companies · $1,378 in 2025
The $1,378 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $488 · 2020: $74.90 · 2021: $35.68 · 2022: $36.51 · 2023: $119 · 2024: $275 · 2025: $1,378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,170 · Food and Beverage: $602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,170.02 |
| Food and Beverage | $602.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,323.72 | 2025 | Inspire |
| Glaxosmithkline, LLC. | $325.61 | 2019-2025 | Nucala |
| Amgen INC. | $150.00 | 2024 | Krystexxa |
| Harmony Biosciences LLC | $124.99 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.47 | 2019 | |
| Djo, LLC | $75.00 | 2023 | Cmf |
| Regeneron Healthcare Solutions, INC. | $49.48 | 2019 | |
| Merck Sharp & Dohme LLC | $39.65 | 2019-2020 | |
| Electromed, INC. | $31.63 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $31.16 | 2019-2021 | |
| Insmed, INC. | $28.17 | 2025 | Brinsupri, Arikayce |
| Jazz Pharmaceuticals INC. | $21.09 | 2019 | |
| Grifols USA, LLC | $19.97 | 2019 | |
| Advanced Respiratory, INC | $19.33 | 2019 | |
| Abbvie INC. | $19.05 | 2023 | Dalvance |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $16.25 | 2019 | |
| Mylan Specialty L.P. | $14.49 | 2019 | |
| Philips North America LLC | $14.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ami Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.